Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms Biomedicines
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF LEUKEMIA RES
The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer Nat Commun
Serum DNA methylome of the colorectal cancer serrated pathway enables non-invasive detection Mol Oncol
MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis Nat Cell Biol
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial Lancet Oncol
Opportunistic genetic screening increases the diagnostic yield and is medically valuable for care of patients and their relatives with hereditary cancer J Med Genet
CompCorona: A web application for comparative transcriptome analyses of coronaviruses reveals SARS-CoV-2-specific host response Turk J Biol